Molina Healthcare (NYSE:MOH) PT Lowered to $430.00

Molina Healthcare (NYSE:MOH - Get Free Report) had its price objective cut by equities research analysts at Barclays from $437.00 to $430.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an "equal weight" rating on the stock. Barclays's price objective would indicate a potential upside of 22.06% from the stock's current price.

MOH has been the subject of a number of other research reports. Stephens restated an "equal weight" rating and set a $390.00 target price on shares of Molina Healthcare in a research report on Thursday. StockNews.com lowered Molina Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Thursday, February 8th. Bank of America cut Molina Healthcare from a "neutral" rating to an "underperform" rating and set a $439.00 target price on the stock. in a report on Thursday, March 28th. Wells Fargo & Company dropped their price target on Molina Healthcare from $440.00 to $410.00 and set an "equal weight" rating for the company in a research note on Monday, April 15th. Finally, Truist Financial lifted their price objective on Molina Healthcare from $435.00 to $460.00 and gave the stock a "buy" rating in a research note on Tuesday, February 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of "Hold" and a consensus price target of $396.09.

Molina Healthcare Price Performance

NYSE:MOH traded down $15.11 on Thursday, reaching $352.30. 914,966 shares of the company's stock traded hands, compared to its average volume of 401,848. The stock has a 50-day simple moving average of $392.45 and a 200-day simple moving average of $372.01. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The firm has a market cap of $20.64 billion, a PE ratio of 18.82, a P/E/G ratio of 1.02 and a beta of 0.47. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.46 by $0.27. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The firm had revenue of $9.93 billion during the quarter, compared to analysts' expectations of $9.45 billion. During the same quarter last year, the business posted $5.81 earnings per share. The firm's revenue was up 21.9% on a year-over-year basis. Equities research analysts forecast that Molina Healthcare will post 23.62 earnings per share for the current year.

Insider Activity

In related news, Director Richard M. Schapiro sold 1,000 shares of the firm's stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the completion of the sale, the director now directly owns 11,207 shares in the company, valued at $4,494,567.35. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the sale, the director now directly owns 12,207 shares in the company, valued at $4,688,220.42. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Richard M. Schapiro sold 1,000 shares of the business's stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the transaction, the director now owns 11,207 shares of the company's stock, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.10% of the stock is currently owned by insiders.

Institutional Trading of Molina Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Desjardins Global Asset Management Inc. raised its stake in shares of Molina Healthcare by 4.4% during the fourth quarter. Desjardins Global Asset Management Inc. now owns 763 shares of the company's stock valued at $276,000 after acquiring an additional 32 shares in the last quarter. Ritholtz Wealth Management raised its position in Molina Healthcare by 2.1% during the 4th quarter. Ritholtz Wealth Management now owns 1,620 shares of the company's stock valued at $585,000 after purchasing an additional 33 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Molina Healthcare by 11.5% during the first quarter. GAMMA Investing LLC now owns 330 shares of the company's stock valued at $136,000 after buying an additional 34 shares during the period. Fifth Third Bancorp increased its stake in shares of Molina Healthcare by 1.8% during the first quarter. Fifth Third Bancorp now owns 2,003 shares of the company's stock valued at $823,000 after buying an additional 35 shares during the period. Finally, New York Life Investment Management LLC lifted its stake in Molina Healthcare by 0.4% in the third quarter. New York Life Investment Management LLC now owns 8,495 shares of the company's stock worth $2,785,000 after acquiring an additional 36 shares during the period. Hedge funds and other institutional investors own 98.50% of the company's stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.